These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26643783)

  • 1. Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis.
    Lin TT; Chiang JY; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Lin JL; Lin LY
    Sci Rep; 2015 Dec; 5():17731. PubMed ID: 26643783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
    Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
    Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.
    Ho LT; Lin LY; Yang YH; Wu CK; Juang JM; Wang YC; Tsai CT; Lai LP; Hwang JJ; Chiang FT; Lin JL; Chen PC
    Int J Cardiol; 2015 Dec; 201():538-43. PubMed ID: 26322603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.
    Shen CH; Zheng CM; Kiu KT; Chen HA; Wu CC; Lu KC; Hsu YH; Lin YF; Wang YH
    Medicine (Baltimore); 2016 Jun; 95(25):e3933. PubMed ID: 27336884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy.
    Chung YW; Yang YH; Wu CK; Yu CC; Juang JM; Wang YC; Tsai CT; Lin LY; Lai LP; Hwang JJ; Chiang FT; Chen PC; Lin JL
    Int J Cardiol; 2016 Jan; 202():962-6. PubMed ID: 26323866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD.
    Niu J; Shah MK; Perez JJ; Airy M; Navaneethan SD; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2019 Mar; 73(3):324-331. PubMed ID: 30449517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study.
    Cardona F; Seide H; Cox RA; Pérez CM
    P R Health Sci J; 2003 Jun; 22(2):119-23. PubMed ID: 12866134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
    Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
    BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis.
    Lin TT; Wu CC; Yang YH; Lin LY; Lin JL; Chen PC; Hwang JJ
    PLoS One; 2016; 11(8):e0160436. PubMed ID: 27513562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.
    Liao JN; Chao TF; Liu CJ; Wang KL; Chen SJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Chen SA
    Kidney Int; 2015 Jun; 87(6):1209-15. PubMed ID: 25587708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenteric ischemia in patients with end-stage renal disease: a nationwide longitudinal study.
    Li SY; Chen YT; Chen TJ; Tsai LW; Yang WC; Chen TW
    Am J Nephrol; 2012; 35(6):491-7. PubMed ID: 22572613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients.
    Buiten MS; de Bie MK; Rotmans JI; Gabreëls BA; van Dorp W; Wolterbeek R; Trines SA; Schalij MJ; Jukema JW; Rabelink TJ; van Erven L
    Heart; 2014 May; 100(9):685-90. PubMed ID: 24670418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.
    Nasr IA; Bouzamondo A; Hulot JS; Dubourg O; Le Heuzey JY; Lechat P
    Eur Heart J; 2007 Feb; 28(4):457-62. PubMed ID: 17289748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Blockers could improve the 28-day and 3-year survival of patients with end-stage renal disease: a retrospective cohort study.
    Dong H; Zhou L; Yang L; Lu H; Cao S; Song H; Fu S
    Int Urol Nephrol; 2023 Jun; 55(6):1597-1607. PubMed ID: 36719527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.